Skip to main content
2025 DC/CSEM Professional Conference Main banner
On-Demand

CCE Stream

DCS15 - Beyond Basics: Further Topics in Diabetes Technology

Friday, November 28, 2025
16:00 - 17:15 Toronto
Location: Room 206

    Speaker(s)

  • Alanna Weisman, MD, PhD, FRCPC (she/her/hers)

    Assistant Professor
    University of Toronto
    University of Toronto
    Toronto, Ontario, Canada

    Disclosure(s): Breakthrough T1D: Grant/Research Support (Ongoing); Canadian Institutes of Health Research (CIHR): Grant/Research Support (Terminated, September 1, 2025); CPD Network: Speaker/Honoraria (Ongoing); Diabetes Canada: Grant/Research Support (Ongoing); Diabetes Care Community: Speaker/Honoraria (Ongoing); Noble Insights: Speaker/Honoraria (Terminated, September 1, 2025); Ontario Health: Grant/Research Support (Ongoing)

  • Michael C. Riddell, PhD

    Professor
    York University
    Toronto, Ontario, Canada

    Disclosure(s): Dexcom: Consultant (Ongoing); Insulet Canada: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Speaker/Honoraria (Terminated); Zucara Theraputics: Advisory Board (Ongoing), Employment (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

  • Rémi Rabasa-Lhoret, MD, PhD (he/him/his)

    Endocrinologist & Associate Professor
    IRCM, CHUM
    Montreal, Quebec, Canada

    Disclosure(s): 35Pharma Inc: Advisory Board (Ongoing); Abbott: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Dexcom: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Advisory Board (Ongoing); Insulet: Advisory Board (Ongoing); Novo-Nordisk: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Sanofi-Aventis: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Ypsomed: Advisory Board (Ongoing)

    • Moderator(s)

  • Bikrampal Sidhu, MSc, MHPE, MD, FRCPC (he/him/his)

    Assistant Professor
    Queen's University
    Queen's University
    Kingston, Ontario, Canada

    Disclosure(s): Abbott: Speaker/Honoraria (Terminated, January 1, 2025); NovoNordisk: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)

Disclosure(s):
Alanna Weisman, MD, PhD, FRCPC: Breakthrough T1D: Grant/Research Support (Ongoing); Canadian Institutes of Health Research (CIHR): Grant/Research Support (Terminated, September 1, 2025); CPD Network: Speaker/Honoraria (Ongoing); Diabetes Canada: Grant/Research Support (Ongoing); Diabetes Care Community: Speaker/Honoraria (Ongoing); Noble Insights: Speaker/Honoraria (Terminated, September 1, 2025); Ontario Health: Grant/Research Support (Ongoing)
Michael C. Riddell, PhD: Dexcom: Consultant (Ongoing); Insulet Canada: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Speaker/Honoraria (Terminated); Zucara Theraputics: Advisory Board (Ongoing), Employment (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Rémi Rabasa-Lhoret, MD, PhD: 35Pharma Inc: Advisory Board (Ongoing); Abbott: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Dexcom: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Advisory Board (Ongoing); Insulet: Advisory Board (Ongoing); Novo-Nordisk: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Sanofi-Aventis: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Ypsomed: Advisory Board (Ongoing)
Bikrampal Sidhu, MSc, MHPE, MD, FRCPC: Abbott: Speaker/Honoraria (Terminated, January 1, 2025); NovoNordisk: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)
Learning Objectives: This session will:
1. Examine the barriers to equitable access to advanced diabetes technologies—including insulin pumps, continuous glucose monitors, and automated insulin delivery systems—and identify strategies to improve access across diverse populations.
2. Optimize AID including DIY looping for high performance exercise.
3. Discuss future directions in diabetes technology: dual hormone pumps and adjunctive therapies.